Global Porcine Circovirus Type 2 (PCV2) Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Porcine Circovirus Type 2 (PCV2) Vaccine market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Porcine circovirus type 2 mainly causes multisystem failure disease characterized by generalized lymphadenopathy in pigs, clinically manifested as multisystem failure syndrome, porcine dermatitis and nephritic syndrome, and porcine respiratory disease syndrome in weaned piglets , sow reproductive disorders, necrotizing lymphadenitis, granulomatous enteritis and exudative epidermatitis, etc. The vaccine can significantly improve the production performance of pig farms, significantly increase the growth rate, survival rate and feed utilization rate of pigs at all stages, and significantly reduce the incidence of disease and death rate.
This report is a detailed and comprehensive analysis for global Porcine Circovirus Type 2 (PCV2) Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Porcine Circovirus Type 2 (PCV2) Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (US$/Dose), 2018-2029
Global Porcine Circovirus Type 2 (PCV2) Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (US$/Dose), 2018-2029
Global Porcine Circovirus Type 2 (PCV2) Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (US$/Dose), 2018-2029
Global Porcine Circovirus Type 2 (PCV2) Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Doses), and ASP (US$/Dose), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Porcine Circovirus Type 2 (PCV2) Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Porcine Circovirus Type 2 (PCV2) Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Zoetis Animal Health, Boehringer-Ingelheim, Merck Animal Health, Ceva Sant? Animale and MSD Animal Health, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Porcine Circovirus Type 2 (PCV2) Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Porcine Circovirus Type 2 (PCV2) Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Porcine Circovirus Type 2 (PCV2) Vaccine, with price, sales, revenue and global market share of Porcine Circovirus Type 2 (PCV2) Vaccine from 2018 to 2023.
Chapter 3, the Porcine Circovirus Type 2 (PCV2) Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Porcine Circovirus Type 2 (PCV2) Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Porcine Circovirus Type 2 (PCV2) Vaccine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Porcine Circovirus Type 2 (PCV2) Vaccine.
Chapter 14 and 15, to describe Porcine Circovirus Type 2 (PCV2) Vaccine sales channel, distributors, customers, research findings and conclusion.
Porcine circovirus type 2 mainly causes multisystem failure disease characterized by generalized lymphadenopathy in pigs, clinically manifested as multisystem failure syndrome, porcine dermatitis and nephritic syndrome, and porcine respiratory disease syndrome in weaned piglets , sow reproductive disorders, necrotizing lymphadenitis, granulomatous enteritis and exudative epidermatitis, etc. The vaccine can significantly improve the production performance of pig farms, significantly increase the growth rate, survival rate and feed utilization rate of pigs at all stages, and significantly reduce the incidence of disease and death rate.
This report is a detailed and comprehensive analysis for global Porcine Circovirus Type 2 (PCV2) Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Porcine Circovirus Type 2 (PCV2) Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (US$/Dose), 2018-2029
Global Porcine Circovirus Type 2 (PCV2) Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (US$/Dose), 2018-2029
Global Porcine Circovirus Type 2 (PCV2) Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Doses), and average selling prices (US$/Dose), 2018-2029
Global Porcine Circovirus Type 2 (PCV2) Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Doses), and ASP (US$/Dose), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Porcine Circovirus Type 2 (PCV2) Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Porcine Circovirus Type 2 (PCV2) Vaccine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Zoetis Animal Health, Boehringer-Ingelheim, Merck Animal Health, Ceva Sant? Animale and MSD Animal Health, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Porcine Circovirus Type 2 (PCV2) Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- WH Type
- LG Type
- SH Type
- SD Type
- ZJ C Type
- Others
- Piglets
- Adults Pigs
- Zoetis Animal Health
- Boehringer-Ingelheim
- Merck Animal Health
- Ceva Sant? Animale
- MSD Animal Health
- SPAH
- Nanjing Tianbang Biological Technology
- Sichuan Huapai Bio-pharmaceutical
- Guangdong Winsun Bio Pharmaceutical
- Wuhan Keqian Biology
- Shanghai Hile Bio-Technology
- Harbin Pharmaceutical Group Bio-Vaccine
- Ringpu
- Shandong Huahong Bioengineering
- Weike Biotechnology
- Nanjing Tianbang Biological Technology
- China Animal Husbandry Industry
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Porcine Circovirus Type 2 (PCV2) Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Porcine Circovirus Type 2 (PCV2) Vaccine, with price, sales, revenue and global market share of Porcine Circovirus Type 2 (PCV2) Vaccine from 2018 to 2023.
Chapter 3, the Porcine Circovirus Type 2 (PCV2) Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Porcine Circovirus Type 2 (PCV2) Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Porcine Circovirus Type 2 (PCV2) Vaccine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Porcine Circovirus Type 2 (PCV2) Vaccine.
Chapter 14 and 15, to describe Porcine Circovirus Type 2 (PCV2) Vaccine sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Porcine Circovirus Type 2 (PCV2) Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 WH Type
1.3.3 LG Type
1.3.4 SH Type
1.3.5 SD Type
1.3.6 ZJ C Type
1.3.7 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Piglets
1.4.3 Adults Pigs
1.5 Global Porcine Circovirus Type 2 (PCV2) Vaccine Market Size & Forecast
1.5.1 Global Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity (2018-2029)
1.5.3 Global Porcine Circovirus Type 2 (PCV2) Vaccine Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Zoetis Animal Health
2.1.1 Zoetis Animal Health Details
2.1.2 Zoetis Animal Health Major Business
2.1.3 Zoetis Animal Health Porcine Circovirus Type 2 (PCV2) Vaccine Product and Services
2.1.4 Zoetis Animal Health Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Zoetis Animal Health Recent Developments/Updates
2.2 Boehringer-Ingelheim
2.2.1 Boehringer-Ingelheim Details
2.2.2 Boehringer-Ingelheim Major Business
2.2.3 Boehringer-Ingelheim Porcine Circovirus Type 2 (PCV2) Vaccine Product and Services
2.2.4 Boehringer-Ingelheim Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Boehringer-Ingelheim Recent Developments/Updates
2.3 Merck Animal Health
2.3.1 Merck Animal Health Details
2.3.2 Merck Animal Health Major Business
2.3.3 Merck Animal Health Porcine Circovirus Type 2 (PCV2) Vaccine Product and Services
2.3.4 Merck Animal Health Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Merck Animal Health Recent Developments/Updates
2.4 Ceva Sant? Animale
2.4.1 Ceva Sant? Animale Details
2.4.2 Ceva Sant? Animale Major Business
2.4.3 Ceva Sant? Animale Porcine Circovirus Type 2 (PCV2) Vaccine Product and Services
2.4.4 Ceva Sant? Animale Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Ceva Sant? Animale Recent Developments/Updates
2.5 MSD Animal Health
2.5.1 MSD Animal Health Details
2.5.2 MSD Animal Health Major Business
2.5.3 MSD Animal Health Porcine Circovirus Type 2 (PCV2) Vaccine Product and Services
2.5.4 MSD Animal Health Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 MSD Animal Health Recent Developments/Updates
2.6 SPAH
2.6.1 SPAH Details
2.6.2 SPAH Major Business
2.6.3 SPAH Porcine Circovirus Type 2 (PCV2) Vaccine Product and Services
2.6.4 SPAH Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 SPAH Recent Developments/Updates
2.7 Nanjing Tianbang Biological Technology
2.7.1 Nanjing Tianbang Biological Technology Details
2.7.2 Nanjing Tianbang Biological Technology Major Business
2.7.3 Nanjing Tianbang Biological Technology Porcine Circovirus Type 2 (PCV2) Vaccine Product and Services
2.7.4 Nanjing Tianbang Biological Technology Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Nanjing Tianbang Biological Technology Recent Developments/Updates
2.8 Sichuan Huapai Bio-pharmaceutical
2.8.1 Sichuan Huapai Bio-pharmaceutical Details
2.8.2 Sichuan Huapai Bio-pharmaceutical Major Business
2.8.3 Sichuan Huapai Bio-pharmaceutical Porcine Circovirus Type 2 (PCV2) Vaccine Product and Services
2.8.4 Sichuan Huapai Bio-pharmaceutical Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Sichuan Huapai Bio-pharmaceutical Recent Developments/Updates
2.9 Guangdong Winsun Bio Pharmaceutical
2.9.1 Guangdong Winsun Bio Pharmaceutical Details
2.9.2 Guangdong Winsun Bio Pharmaceutical Major Business
2.9.3 Guangdong Winsun Bio Pharmaceutical Porcine Circovirus Type 2 (PCV2) Vaccine Product and Services
2.9.4 Guangdong Winsun Bio Pharmaceutical Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Guangdong Winsun Bio Pharmaceutical Recent Developments/Updates
2.10 Wuhan Keqian Biology
2.10.1 Wuhan Keqian Biology Details
2.10.2 Wuhan Keqian Biology Major Business
2.10.3 Wuhan Keqian Biology Porcine Circovirus Type 2 (PCV2) Vaccine Product and Services
2.10.4 Wuhan Keqian Biology Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Wuhan Keqian Biology Recent Developments/Updates
2.11 Shanghai Hile Bio-Technology
2.11.1 Shanghai Hile Bio-Technology Details
2.11.2 Shanghai Hile Bio-Technology Major Business
2.11.3 Shanghai Hile Bio-Technology Porcine Circovirus Type 2 (PCV2) Vaccine Product and Services
2.11.4 Shanghai Hile Bio-Technology Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Shanghai Hile Bio-Technology Recent Developments/Updates
2.12 Harbin Pharmaceutical Group Bio-Vaccine
2.12.1 Harbin Pharmaceutical Group Bio-Vaccine Details
2.12.2 Harbin Pharmaceutical Group Bio-Vaccine Major Business
2.12.3 Harbin Pharmaceutical Group Bio-Vaccine Porcine Circovirus Type 2 (PCV2) Vaccine Product and Services
2.12.4 Harbin Pharmaceutical Group Bio-Vaccine Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Harbin Pharmaceutical Group Bio-Vaccine Recent Developments/Updates
2.13 Ringpu
2.13.1 Ringpu Details
2.13.2 Ringpu Major Business
2.13.3 Ringpu Porcine Circovirus Type 2 (PCV2) Vaccine Product and Services
2.13.4 Ringpu Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Ringpu Recent Developments/Updates
2.14 Shandong Huahong Bioengineering
2.14.1 Shandong Huahong Bioengineering Details
2.14.2 Shandong Huahong Bioengineering Major Business
2.14.3 Shandong Huahong Bioengineering Porcine Circovirus Type 2 (PCV2) Vaccine Product and Services
2.14.4 Shandong Huahong Bioengineering Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Shandong Huahong Bioengineering Recent Developments/Updates
2.15 Weike Biotechnology
2.15.1 Weike Biotechnology Details
2.15.2 Weike Biotechnology Major Business
2.15.3 Weike Biotechnology Porcine Circovirus Type 2 (PCV2) Vaccine Product and Services
2.15.4 Weike Biotechnology Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Weike Biotechnology Recent Developments/Updates
2.16 Nanjing Tianbang Biological Technology
2.16.1 Nanjing Tianbang Biological Technology Details
2.16.2 Nanjing Tianbang Biological Technology Major Business
2.16.3 Nanjing Tianbang Biological Technology Porcine Circovirus Type 2 (PCV2) Vaccine Product and Services
2.16.4 Nanjing Tianbang Biological Technology Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Nanjing Tianbang Biological Technology Recent Developments/Updates
2.17 China Animal Husbandry Industry
2.17.1 China Animal Husbandry Industry Details
2.17.2 China Animal Husbandry Industry Major Business
2.17.3 China Animal Husbandry Industry Porcine Circovirus Type 2 (PCV2) Vaccine Product and Services
2.17.4 China Animal Husbandry Industry Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 China Animal Husbandry Industry Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: PORCINE CIRCOVIRUS TYPE 2 (PCV2) VACCINE BY MANUFACTURER
3.1 Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Manufacturer (2018-2023)
3.2 Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Manufacturer (2018-2023)
3.3 Global Porcine Circovirus Type 2 (PCV2) Vaccine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Porcine Circovirus Type 2 (PCV2) Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Porcine Circovirus Type 2 (PCV2) Vaccine Manufacturer Market Share in 2022
3.4.2 Top 6 Porcine Circovirus Type 2 (PCV2) Vaccine Manufacturer Market Share in 2022
3.5 Porcine Circovirus Type 2 (PCV2) Vaccine Market: Overall Company Footprint Analysis
3.5.1 Porcine Circovirus Type 2 (PCV2) Vaccine Market: Region Footprint
3.5.2 Porcine Circovirus Type 2 (PCV2) Vaccine Market: Company Product Type Footprint
3.5.3 Porcine Circovirus Type 2 (PCV2) Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Porcine Circovirus Type 2 (PCV2) Vaccine Market Size by Region
4.1.1 Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Region (2018-2029)
4.1.2 Global Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value by Region (2018-2029)
4.1.3 Global Porcine Circovirus Type 2 (PCV2) Vaccine Average Price by Region (2018-2029)
4.2 North America Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value (2018-2029)
4.3 Europe Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value (2018-2029)
4.4 Asia-Pacific Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value (2018-2029)
4.5 South America Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value (2018-2029)
4.6 Middle East and Africa Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Type (2018-2029)
5.2 Global Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value by Type (2018-2029)
5.3 Global Porcine Circovirus Type 2 (PCV2) Vaccine Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Application (2018-2029)
6.2 Global Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value by Application (2018-2029)
6.3 Global Porcine Circovirus Type 2 (PCV2) Vaccine Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Type (2018-2029)
7.2 North America Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Application (2018-2029)
7.3 North America Porcine Circovirus Type 2 (PCV2) Vaccine Market Size by Country
7.3.1 North America Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Country (2018-2029)
7.3.2 North America Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Type (2018-2029)
8.2 Europe Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Application (2018-2029)
8.3 Europe Porcine Circovirus Type 2 (PCV2) Vaccine Market Size by Country
8.3.1 Europe Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Country (2018-2029)
8.3.2 Europe Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Porcine Circovirus Type 2 (PCV2) Vaccine Market Size by Region
9.3.1 Asia-Pacific Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Type (2018-2029)
10.2 South America Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Application (2018-2029)
10.3 South America Porcine Circovirus Type 2 (PCV2) Vaccine Market Size by Country
10.3.1 South America Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Country (2018-2029)
10.3.2 South America Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Porcine Circovirus Type 2 (PCV2) Vaccine Market Size by Country
11.3.1 Middle East & Africa Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Porcine Circovirus Type 2 (PCV2) Vaccine Market Drivers
12.2 Porcine Circovirus Type 2 (PCV2) Vaccine Market Restraints
12.3 Porcine Circovirus Type 2 (PCV2) Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Porcine Circovirus Type 2 (PCV2) Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Porcine Circovirus Type 2 (PCV2) Vaccine
13.3 Porcine Circovirus Type 2 (PCV2) Vaccine Production Process
13.4 Porcine Circovirus Type 2 (PCV2) Vaccine Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Porcine Circovirus Type 2 (PCV2) Vaccine Typical Distributors
14.3 Porcine Circovirus Type 2 (PCV2) Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Porcine Circovirus Type 2 (PCV2) Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 WH Type
1.3.3 LG Type
1.3.4 SH Type
1.3.5 SD Type
1.3.6 ZJ C Type
1.3.7 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Piglets
1.4.3 Adults Pigs
1.5 Global Porcine Circovirus Type 2 (PCV2) Vaccine Market Size & Forecast
1.5.1 Global Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity (2018-2029)
1.5.3 Global Porcine Circovirus Type 2 (PCV2) Vaccine Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Zoetis Animal Health
2.1.1 Zoetis Animal Health Details
2.1.2 Zoetis Animal Health Major Business
2.1.3 Zoetis Animal Health Porcine Circovirus Type 2 (PCV2) Vaccine Product and Services
2.1.4 Zoetis Animal Health Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Zoetis Animal Health Recent Developments/Updates
2.2 Boehringer-Ingelheim
2.2.1 Boehringer-Ingelheim Details
2.2.2 Boehringer-Ingelheim Major Business
2.2.3 Boehringer-Ingelheim Porcine Circovirus Type 2 (PCV2) Vaccine Product and Services
2.2.4 Boehringer-Ingelheim Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Boehringer-Ingelheim Recent Developments/Updates
2.3 Merck Animal Health
2.3.1 Merck Animal Health Details
2.3.2 Merck Animal Health Major Business
2.3.3 Merck Animal Health Porcine Circovirus Type 2 (PCV2) Vaccine Product and Services
2.3.4 Merck Animal Health Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Merck Animal Health Recent Developments/Updates
2.4 Ceva Sant? Animale
2.4.1 Ceva Sant? Animale Details
2.4.2 Ceva Sant? Animale Major Business
2.4.3 Ceva Sant? Animale Porcine Circovirus Type 2 (PCV2) Vaccine Product and Services
2.4.4 Ceva Sant? Animale Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Ceva Sant? Animale Recent Developments/Updates
2.5 MSD Animal Health
2.5.1 MSD Animal Health Details
2.5.2 MSD Animal Health Major Business
2.5.3 MSD Animal Health Porcine Circovirus Type 2 (PCV2) Vaccine Product and Services
2.5.4 MSD Animal Health Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 MSD Animal Health Recent Developments/Updates
2.6 SPAH
2.6.1 SPAH Details
2.6.2 SPAH Major Business
2.6.3 SPAH Porcine Circovirus Type 2 (PCV2) Vaccine Product and Services
2.6.4 SPAH Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 SPAH Recent Developments/Updates
2.7 Nanjing Tianbang Biological Technology
2.7.1 Nanjing Tianbang Biological Technology Details
2.7.2 Nanjing Tianbang Biological Technology Major Business
2.7.3 Nanjing Tianbang Biological Technology Porcine Circovirus Type 2 (PCV2) Vaccine Product and Services
2.7.4 Nanjing Tianbang Biological Technology Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Nanjing Tianbang Biological Technology Recent Developments/Updates
2.8 Sichuan Huapai Bio-pharmaceutical
2.8.1 Sichuan Huapai Bio-pharmaceutical Details
2.8.2 Sichuan Huapai Bio-pharmaceutical Major Business
2.8.3 Sichuan Huapai Bio-pharmaceutical Porcine Circovirus Type 2 (PCV2) Vaccine Product and Services
2.8.4 Sichuan Huapai Bio-pharmaceutical Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Sichuan Huapai Bio-pharmaceutical Recent Developments/Updates
2.9 Guangdong Winsun Bio Pharmaceutical
2.9.1 Guangdong Winsun Bio Pharmaceutical Details
2.9.2 Guangdong Winsun Bio Pharmaceutical Major Business
2.9.3 Guangdong Winsun Bio Pharmaceutical Porcine Circovirus Type 2 (PCV2) Vaccine Product and Services
2.9.4 Guangdong Winsun Bio Pharmaceutical Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Guangdong Winsun Bio Pharmaceutical Recent Developments/Updates
2.10 Wuhan Keqian Biology
2.10.1 Wuhan Keqian Biology Details
2.10.2 Wuhan Keqian Biology Major Business
2.10.3 Wuhan Keqian Biology Porcine Circovirus Type 2 (PCV2) Vaccine Product and Services
2.10.4 Wuhan Keqian Biology Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Wuhan Keqian Biology Recent Developments/Updates
2.11 Shanghai Hile Bio-Technology
2.11.1 Shanghai Hile Bio-Technology Details
2.11.2 Shanghai Hile Bio-Technology Major Business
2.11.3 Shanghai Hile Bio-Technology Porcine Circovirus Type 2 (PCV2) Vaccine Product and Services
2.11.4 Shanghai Hile Bio-Technology Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Shanghai Hile Bio-Technology Recent Developments/Updates
2.12 Harbin Pharmaceutical Group Bio-Vaccine
2.12.1 Harbin Pharmaceutical Group Bio-Vaccine Details
2.12.2 Harbin Pharmaceutical Group Bio-Vaccine Major Business
2.12.3 Harbin Pharmaceutical Group Bio-Vaccine Porcine Circovirus Type 2 (PCV2) Vaccine Product and Services
2.12.4 Harbin Pharmaceutical Group Bio-Vaccine Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Harbin Pharmaceutical Group Bio-Vaccine Recent Developments/Updates
2.13 Ringpu
2.13.1 Ringpu Details
2.13.2 Ringpu Major Business
2.13.3 Ringpu Porcine Circovirus Type 2 (PCV2) Vaccine Product and Services
2.13.4 Ringpu Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Ringpu Recent Developments/Updates
2.14 Shandong Huahong Bioengineering
2.14.1 Shandong Huahong Bioengineering Details
2.14.2 Shandong Huahong Bioengineering Major Business
2.14.3 Shandong Huahong Bioengineering Porcine Circovirus Type 2 (PCV2) Vaccine Product and Services
2.14.4 Shandong Huahong Bioengineering Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Shandong Huahong Bioengineering Recent Developments/Updates
2.15 Weike Biotechnology
2.15.1 Weike Biotechnology Details
2.15.2 Weike Biotechnology Major Business
2.15.3 Weike Biotechnology Porcine Circovirus Type 2 (PCV2) Vaccine Product and Services
2.15.4 Weike Biotechnology Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Weike Biotechnology Recent Developments/Updates
2.16 Nanjing Tianbang Biological Technology
2.16.1 Nanjing Tianbang Biological Technology Details
2.16.2 Nanjing Tianbang Biological Technology Major Business
2.16.3 Nanjing Tianbang Biological Technology Porcine Circovirus Type 2 (PCV2) Vaccine Product and Services
2.16.4 Nanjing Tianbang Biological Technology Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Nanjing Tianbang Biological Technology Recent Developments/Updates
2.17 China Animal Husbandry Industry
2.17.1 China Animal Husbandry Industry Details
2.17.2 China Animal Husbandry Industry Major Business
2.17.3 China Animal Husbandry Industry Porcine Circovirus Type 2 (PCV2) Vaccine Product and Services
2.17.4 China Animal Husbandry Industry Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 China Animal Husbandry Industry Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: PORCINE CIRCOVIRUS TYPE 2 (PCV2) VACCINE BY MANUFACTURER
3.1 Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Manufacturer (2018-2023)
3.2 Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Manufacturer (2018-2023)
3.3 Global Porcine Circovirus Type 2 (PCV2) Vaccine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Porcine Circovirus Type 2 (PCV2) Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Porcine Circovirus Type 2 (PCV2) Vaccine Manufacturer Market Share in 2022
3.4.2 Top 6 Porcine Circovirus Type 2 (PCV2) Vaccine Manufacturer Market Share in 2022
3.5 Porcine Circovirus Type 2 (PCV2) Vaccine Market: Overall Company Footprint Analysis
3.5.1 Porcine Circovirus Type 2 (PCV2) Vaccine Market: Region Footprint
3.5.2 Porcine Circovirus Type 2 (PCV2) Vaccine Market: Company Product Type Footprint
3.5.3 Porcine Circovirus Type 2 (PCV2) Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Porcine Circovirus Type 2 (PCV2) Vaccine Market Size by Region
4.1.1 Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Region (2018-2029)
4.1.2 Global Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value by Region (2018-2029)
4.1.3 Global Porcine Circovirus Type 2 (PCV2) Vaccine Average Price by Region (2018-2029)
4.2 North America Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value (2018-2029)
4.3 Europe Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value (2018-2029)
4.4 Asia-Pacific Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value (2018-2029)
4.5 South America Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value (2018-2029)
4.6 Middle East and Africa Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Type (2018-2029)
5.2 Global Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value by Type (2018-2029)
5.3 Global Porcine Circovirus Type 2 (PCV2) Vaccine Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Application (2018-2029)
6.2 Global Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value by Application (2018-2029)
6.3 Global Porcine Circovirus Type 2 (PCV2) Vaccine Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Type (2018-2029)
7.2 North America Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Application (2018-2029)
7.3 North America Porcine Circovirus Type 2 (PCV2) Vaccine Market Size by Country
7.3.1 North America Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Country (2018-2029)
7.3.2 North America Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Type (2018-2029)
8.2 Europe Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Application (2018-2029)
8.3 Europe Porcine Circovirus Type 2 (PCV2) Vaccine Market Size by Country
8.3.1 Europe Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Country (2018-2029)
8.3.2 Europe Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Porcine Circovirus Type 2 (PCV2) Vaccine Market Size by Region
9.3.1 Asia-Pacific Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Type (2018-2029)
10.2 South America Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Application (2018-2029)
10.3 South America Porcine Circovirus Type 2 (PCV2) Vaccine Market Size by Country
10.3.1 South America Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Country (2018-2029)
10.3.2 South America Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Porcine Circovirus Type 2 (PCV2) Vaccine Market Size by Country
11.3.1 Middle East & Africa Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Porcine Circovirus Type 2 (PCV2) Vaccine Market Drivers
12.2 Porcine Circovirus Type 2 (PCV2) Vaccine Market Restraints
12.3 Porcine Circovirus Type 2 (PCV2) Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Porcine Circovirus Type 2 (PCV2) Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Porcine Circovirus Type 2 (PCV2) Vaccine
13.3 Porcine Circovirus Type 2 (PCV2) Vaccine Production Process
13.4 Porcine Circovirus Type 2 (PCV2) Vaccine Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Porcine Circovirus Type 2 (PCV2) Vaccine Typical Distributors
14.3 Porcine Circovirus Type 2 (PCV2) Vaccine Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Zoetis Animal Health Basic Information, Manufacturing Base and Competitors
Table 4. Zoetis Animal Health Major Business
Table 5. Zoetis Animal Health Porcine Circovirus Type 2 (PCV2) Vaccine Product and Services
Table 6. Zoetis Animal Health Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Zoetis Animal Health Recent Developments/Updates
Table 8. Boehringer-Ingelheim Basic Information, Manufacturing Base and Competitors
Table 9. Boehringer-Ingelheim Major Business
Table 10. Boehringer-Ingelheim Porcine Circovirus Type 2 (PCV2) Vaccine Product and Services
Table 11. Boehringer-Ingelheim Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Boehringer-Ingelheim Recent Developments/Updates
Table 13. Merck Animal Health Basic Information, Manufacturing Base and Competitors
Table 14. Merck Animal Health Major Business
Table 15. Merck Animal Health Porcine Circovirus Type 2 (PCV2) Vaccine Product and Services
Table 16. Merck Animal Health Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Merck Animal Health Recent Developments/Updates
Table 18. Ceva Sant? Animale Basic Information, Manufacturing Base and Competitors
Table 19. Ceva Sant? Animale Major Business
Table 20. Ceva Sant? Animale Porcine Circovirus Type 2 (PCV2) Vaccine Product and Services
Table 21. Ceva Sant? Animale Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Ceva Sant? Animale Recent Developments/Updates
Table 23. MSD Animal Health Basic Information, Manufacturing Base and Competitors
Table 24. MSD Animal Health Major Business
Table 25. MSD Animal Health Porcine Circovirus Type 2 (PCV2) Vaccine Product and Services
Table 26. MSD Animal Health Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. MSD Animal Health Recent Developments/Updates
Table 28. SPAH Basic Information, Manufacturing Base and Competitors
Table 29. SPAH Major Business
Table 30. SPAH Porcine Circovirus Type 2 (PCV2) Vaccine Product and Services
Table 31. SPAH Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. SPAH Recent Developments/Updates
Table 33. Nanjing Tianbang Biological Technology Basic Information, Manufacturing Base and Competitors
Table 34. Nanjing Tianbang Biological Technology Major Business
Table 35. Nanjing Tianbang Biological Technology Porcine Circovirus Type 2 (PCV2) Vaccine Product and Services
Table 36. Nanjing Tianbang Biological Technology Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Nanjing Tianbang Biological Technology Recent Developments/Updates
Table 38. Sichuan Huapai Bio-pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 39. Sichuan Huapai Bio-pharmaceutical Major Business
Table 40. Sichuan Huapai Bio-pharmaceutical Porcine Circovirus Type 2 (PCV2) Vaccine Product and Services
Table 41. Sichuan Huapai Bio-pharmaceutical Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Sichuan Huapai Bio-pharmaceutical Recent Developments/Updates
Table 43. Guangdong Winsun Bio Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 44. Guangdong Winsun Bio Pharmaceutical Major Business
Table 45. Guangdong Winsun Bio Pharmaceutical Porcine Circovirus Type 2 (PCV2) Vaccine Product and Services
Table 46. Guangdong Winsun Bio Pharmaceutical Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Guangdong Winsun Bio Pharmaceutical Recent Developments/Updates
Table 48. Wuhan Keqian Biology Basic Information, Manufacturing Base and Competitors
Table 49. Wuhan Keqian Biology Major Business
Table 50. Wuhan Keqian Biology Porcine Circovirus Type 2 (PCV2) Vaccine Product and Services
Table 51. Wuhan Keqian Biology Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Wuhan Keqian Biology Recent Developments/Updates
Table 53. Shanghai Hile Bio-Technology Basic Information, Manufacturing Base and Competitors
Table 54. Shanghai Hile Bio-Technology Major Business
Table 55. Shanghai Hile Bio-Technology Porcine Circovirus Type 2 (PCV2) Vaccine Product and Services
Table 56. Shanghai Hile Bio-Technology Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Shanghai Hile Bio-Technology Recent Developments/Updates
Table 58. Harbin Pharmaceutical Group Bio-Vaccine Basic Information, Manufacturing Base and Competitors
Table 59. Harbin Pharmaceutical Group Bio-Vaccine Major Business
Table 60. Harbin Pharmaceutical Group Bio-Vaccine Porcine Circovirus Type 2 (PCV2) Vaccine Product and Services
Table 61. Harbin Pharmaceutical Group Bio-Vaccine Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Harbin Pharmaceutical Group Bio-Vaccine Recent Developments/Updates
Table 63. Ringpu Basic Information, Manufacturing Base and Competitors
Table 64. Ringpu Major Business
Table 65. Ringpu Porcine Circovirus Type 2 (PCV2) Vaccine Product and Services
Table 66. Ringpu Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Ringpu Recent Developments/Updates
Table 68. Shandong Huahong Bioengineering Basic Information, Manufacturing Base and Competitors
Table 69. Shandong Huahong Bioengineering Major Business
Table 70. Shandong Huahong Bioengineering Porcine Circovirus Type 2 (PCV2) Vaccine Product and Services
Table 71. Shandong Huahong Bioengineering Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Shandong Huahong Bioengineering Recent Developments/Updates
Table 73. Weike Biotechnology Basic Information, Manufacturing Base and Competitors
Table 74. Weike Biotechnology Major Business
Table 75. Weike Biotechnology Porcine Circovirus Type 2 (PCV2) Vaccine Product and Services
Table 76. Weike Biotechnology Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Weike Biotechnology Recent Developments/Updates
Table 78. Nanjing Tianbang Biological Technology Basic Information, Manufacturing Base and Competitors
Table 79. Nanjing Tianbang Biological Technology Major Business
Table 80. Nanjing Tianbang Biological Technology Porcine Circovirus Type 2 (PCV2) Vaccine Product and Services
Table 81. Nanjing Tianbang Biological Technology Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Nanjing Tianbang Biological Technology Recent Developments/Updates
Table 83. China Animal Husbandry Industry Basic Information, Manufacturing Base and Competitors
Table 84. China Animal Husbandry Industry Major Business
Table 85. China Animal Husbandry Industry Porcine Circovirus Type 2 (PCV2) Vaccine Product and Services
Table 86. China Animal Husbandry Industry Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. China Animal Husbandry Industry Recent Developments/Updates
Table 88. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Manufacturer (2018-2023) & (K Doses)
Table 89. Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Manufacturer (2018-2023) & (USD Million)
Table 90. Global Porcine Circovirus Type 2 (PCV2) Vaccine Average Price by Manufacturer (2018-2023) & (US$/Dose)
Table 91. Market Position of Manufacturers in Porcine Circovirus Type 2 (PCV2) Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 92. Head Office and Porcine Circovirus Type 2 (PCV2) Vaccine Production Site of Key Manufacturer
Table 93. Porcine Circovirus Type 2 (PCV2) Vaccine Market: Company Product Type Footprint
Table 94. Porcine Circovirus Type 2 (PCV2) Vaccine Market: Company Product Application Footprint
Table 95. Porcine Circovirus Type 2 (PCV2) Vaccine New Market Entrants and Barriers to Market Entry
Table 96. Porcine Circovirus Type 2 (PCV2) Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 97. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Region (2018-2023) & (K Doses)
Table 98. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Region (2024-2029) & (K Doses)
Table 99. Global Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 100. Global Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 101. Global Porcine Circovirus Type 2 (PCV2) Vaccine Average Price by Region (2018-2023) & (US$/Dose)
Table 102. Global Porcine Circovirus Type 2 (PCV2) Vaccine Average Price by Region (2024-2029) & (US$/Dose)
Table 103. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Type (2018-2023) & (K Doses)
Table 104. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Type (2024-2029) & (K Doses)
Table 105. Global Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value by Type (2018-2023) & (USD Million)
Table 106. Global Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value by Type (2024-2029) & (USD Million)
Table 107. Global Porcine Circovirus Type 2 (PCV2) Vaccine Average Price by Type (2018-2023) & (US$/Dose)
Table 108. Global Porcine Circovirus Type 2 (PCV2) Vaccine Average Price by Type (2024-2029) & (US$/Dose)
Table 109. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Application (2018-2023) & (K Doses)
Table 110. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Application (2024-2029) & (K Doses)
Table 111. Global Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value by Application (2018-2023) & (USD Million)
Table 112. Global Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value by Application (2024-2029) & (USD Million)
Table 113. Global Porcine Circovirus Type 2 (PCV2) Vaccine Average Price by Application (2018-2023) & (US$/Dose)
Table 114. Global Porcine Circovirus Type 2 (PCV2) Vaccine Average Price by Application (2024-2029) & (US$/Dose)
Table 115. North America Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Type (2018-2023) & (K Doses)
Table 116. North America Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Type (2024-2029) & (K Doses)
Table 117. North America Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Application (2018-2023) & (K Doses)
Table 118. North America Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Application (2024-2029) & (K Doses)
Table 119. North America Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Country (2018-2023) & (K Doses)
Table 120. North America Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Country (2024-2029) & (K Doses)
Table 121. North America Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 122. North America Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 123. Europe Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Type (2018-2023) & (K Doses)
Table 124. Europe Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Type (2024-2029) & (K Doses)
Table 125. Europe Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Application (2018-2023) & (K Doses)
Table 126. Europe Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Application (2024-2029) & (K Doses)
Table 127. Europe Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Country (2018-2023) & (K Doses)
Table 128. Europe Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Country (2024-2029) & (K Doses)
Table 129. Europe Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 130. Europe Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 131. Asia-Pacific Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Type (2018-2023) & (K Doses)
Table 132. Asia-Pacific Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Type (2024-2029) & (K Doses)
Table 133. Asia-Pacific Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Application (2018-2023) & (K Doses)
Table 134. Asia-Pacific Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Application (2024-2029) & (K Doses)
Table 135. Asia-Pacific Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Region (2018-2023) & (K Doses)
Table 136. Asia-Pacific Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Region (2024-2029) & (K Doses)
Table 137. Asia-Pacific Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 138. Asia-Pacific Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 139. South America Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Type (2018-2023) & (K Doses)
Table 140. South America Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Type (2024-2029) & (K Doses)
Table 141. South America Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Application (2018-2023) & (K Doses)
Table 142. South America Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Application (2024-2029) & (K Doses)
Table 143. South America Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Country (2018-2023) & (K Doses)
Table 144. South America Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Country (2024-2029) & (K Doses)
Table 145. South America Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 146. South America Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 147. Middle East & Africa Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Type (2018-2023) & (K Doses)
Table 148. Middle East & Africa Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Type (2024-2029) & (K Doses)
Table 149. Middle East & Africa Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Application (2018-2023) & (K Doses)
Table 150. Middle East & Africa Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Application (2024-2029) & (K Doses)
Table 151. Middle East & Africa Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Region (2018-2023) & (K Doses)
Table 152. Middle East & Africa Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Region (2024-2029) & (K Doses)
Table 153. Middle East & Africa Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 154. Middle East & Africa Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 155. Porcine Circovirus Type 2 (PCV2) Vaccine Raw Material
Table 156. Key Manufacturers of Porcine Circovirus Type 2 (PCV2) Vaccine Raw Materials
Table 157. Porcine Circovirus Type 2 (PCV2) Vaccine Typical Distributors
Table 158. Porcine Circovirus Type 2 (PCV2) Vaccine Typical Customers
Table 1. Global Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Zoetis Animal Health Basic Information, Manufacturing Base and Competitors
Table 4. Zoetis Animal Health Major Business
Table 5. Zoetis Animal Health Porcine Circovirus Type 2 (PCV2) Vaccine Product and Services
Table 6. Zoetis Animal Health Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Zoetis Animal Health Recent Developments/Updates
Table 8. Boehringer-Ingelheim Basic Information, Manufacturing Base and Competitors
Table 9. Boehringer-Ingelheim Major Business
Table 10. Boehringer-Ingelheim Porcine Circovirus Type 2 (PCV2) Vaccine Product and Services
Table 11. Boehringer-Ingelheim Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Boehringer-Ingelheim Recent Developments/Updates
Table 13. Merck Animal Health Basic Information, Manufacturing Base and Competitors
Table 14. Merck Animal Health Major Business
Table 15. Merck Animal Health Porcine Circovirus Type 2 (PCV2) Vaccine Product and Services
Table 16. Merck Animal Health Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Merck Animal Health Recent Developments/Updates
Table 18. Ceva Sant? Animale Basic Information, Manufacturing Base and Competitors
Table 19. Ceva Sant? Animale Major Business
Table 20. Ceva Sant? Animale Porcine Circovirus Type 2 (PCV2) Vaccine Product and Services
Table 21. Ceva Sant? Animale Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Ceva Sant? Animale Recent Developments/Updates
Table 23. MSD Animal Health Basic Information, Manufacturing Base and Competitors
Table 24. MSD Animal Health Major Business
Table 25. MSD Animal Health Porcine Circovirus Type 2 (PCV2) Vaccine Product and Services
Table 26. MSD Animal Health Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. MSD Animal Health Recent Developments/Updates
Table 28. SPAH Basic Information, Manufacturing Base and Competitors
Table 29. SPAH Major Business
Table 30. SPAH Porcine Circovirus Type 2 (PCV2) Vaccine Product and Services
Table 31. SPAH Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. SPAH Recent Developments/Updates
Table 33. Nanjing Tianbang Biological Technology Basic Information, Manufacturing Base and Competitors
Table 34. Nanjing Tianbang Biological Technology Major Business
Table 35. Nanjing Tianbang Biological Technology Porcine Circovirus Type 2 (PCV2) Vaccine Product and Services
Table 36. Nanjing Tianbang Biological Technology Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Nanjing Tianbang Biological Technology Recent Developments/Updates
Table 38. Sichuan Huapai Bio-pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 39. Sichuan Huapai Bio-pharmaceutical Major Business
Table 40. Sichuan Huapai Bio-pharmaceutical Porcine Circovirus Type 2 (PCV2) Vaccine Product and Services
Table 41. Sichuan Huapai Bio-pharmaceutical Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Sichuan Huapai Bio-pharmaceutical Recent Developments/Updates
Table 43. Guangdong Winsun Bio Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 44. Guangdong Winsun Bio Pharmaceutical Major Business
Table 45. Guangdong Winsun Bio Pharmaceutical Porcine Circovirus Type 2 (PCV2) Vaccine Product and Services
Table 46. Guangdong Winsun Bio Pharmaceutical Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Guangdong Winsun Bio Pharmaceutical Recent Developments/Updates
Table 48. Wuhan Keqian Biology Basic Information, Manufacturing Base and Competitors
Table 49. Wuhan Keqian Biology Major Business
Table 50. Wuhan Keqian Biology Porcine Circovirus Type 2 (PCV2) Vaccine Product and Services
Table 51. Wuhan Keqian Biology Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Wuhan Keqian Biology Recent Developments/Updates
Table 53. Shanghai Hile Bio-Technology Basic Information, Manufacturing Base and Competitors
Table 54. Shanghai Hile Bio-Technology Major Business
Table 55. Shanghai Hile Bio-Technology Porcine Circovirus Type 2 (PCV2) Vaccine Product and Services
Table 56. Shanghai Hile Bio-Technology Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Shanghai Hile Bio-Technology Recent Developments/Updates
Table 58. Harbin Pharmaceutical Group Bio-Vaccine Basic Information, Manufacturing Base and Competitors
Table 59. Harbin Pharmaceutical Group Bio-Vaccine Major Business
Table 60. Harbin Pharmaceutical Group Bio-Vaccine Porcine Circovirus Type 2 (PCV2) Vaccine Product and Services
Table 61. Harbin Pharmaceutical Group Bio-Vaccine Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Harbin Pharmaceutical Group Bio-Vaccine Recent Developments/Updates
Table 63. Ringpu Basic Information, Manufacturing Base and Competitors
Table 64. Ringpu Major Business
Table 65. Ringpu Porcine Circovirus Type 2 (PCV2) Vaccine Product and Services
Table 66. Ringpu Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Ringpu Recent Developments/Updates
Table 68. Shandong Huahong Bioengineering Basic Information, Manufacturing Base and Competitors
Table 69. Shandong Huahong Bioengineering Major Business
Table 70. Shandong Huahong Bioengineering Porcine Circovirus Type 2 (PCV2) Vaccine Product and Services
Table 71. Shandong Huahong Bioengineering Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Shandong Huahong Bioengineering Recent Developments/Updates
Table 73. Weike Biotechnology Basic Information, Manufacturing Base and Competitors
Table 74. Weike Biotechnology Major Business
Table 75. Weike Biotechnology Porcine Circovirus Type 2 (PCV2) Vaccine Product and Services
Table 76. Weike Biotechnology Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Weike Biotechnology Recent Developments/Updates
Table 78. Nanjing Tianbang Biological Technology Basic Information, Manufacturing Base and Competitors
Table 79. Nanjing Tianbang Biological Technology Major Business
Table 80. Nanjing Tianbang Biological Technology Porcine Circovirus Type 2 (PCV2) Vaccine Product and Services
Table 81. Nanjing Tianbang Biological Technology Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Nanjing Tianbang Biological Technology Recent Developments/Updates
Table 83. China Animal Husbandry Industry Basic Information, Manufacturing Base and Competitors
Table 84. China Animal Husbandry Industry Major Business
Table 85. China Animal Husbandry Industry Porcine Circovirus Type 2 (PCV2) Vaccine Product and Services
Table 86. China Animal Husbandry Industry Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity (K Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. China Animal Husbandry Industry Recent Developments/Updates
Table 88. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Manufacturer (2018-2023) & (K Doses)
Table 89. Global Porcine Circovirus Type 2 (PCV2) Vaccine Revenue by Manufacturer (2018-2023) & (USD Million)
Table 90. Global Porcine Circovirus Type 2 (PCV2) Vaccine Average Price by Manufacturer (2018-2023) & (US$/Dose)
Table 91. Market Position of Manufacturers in Porcine Circovirus Type 2 (PCV2) Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 92. Head Office and Porcine Circovirus Type 2 (PCV2) Vaccine Production Site of Key Manufacturer
Table 93. Porcine Circovirus Type 2 (PCV2) Vaccine Market: Company Product Type Footprint
Table 94. Porcine Circovirus Type 2 (PCV2) Vaccine Market: Company Product Application Footprint
Table 95. Porcine Circovirus Type 2 (PCV2) Vaccine New Market Entrants and Barriers to Market Entry
Table 96. Porcine Circovirus Type 2 (PCV2) Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 97. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Region (2018-2023) & (K Doses)
Table 98. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Region (2024-2029) & (K Doses)
Table 99. Global Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 100. Global Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 101. Global Porcine Circovirus Type 2 (PCV2) Vaccine Average Price by Region (2018-2023) & (US$/Dose)
Table 102. Global Porcine Circovirus Type 2 (PCV2) Vaccine Average Price by Region (2024-2029) & (US$/Dose)
Table 103. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Type (2018-2023) & (K Doses)
Table 104. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Type (2024-2029) & (K Doses)
Table 105. Global Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value by Type (2018-2023) & (USD Million)
Table 106. Global Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value by Type (2024-2029) & (USD Million)
Table 107. Global Porcine Circovirus Type 2 (PCV2) Vaccine Average Price by Type (2018-2023) & (US$/Dose)
Table 108. Global Porcine Circovirus Type 2 (PCV2) Vaccine Average Price by Type (2024-2029) & (US$/Dose)
Table 109. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Application (2018-2023) & (K Doses)
Table 110. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Application (2024-2029) & (K Doses)
Table 111. Global Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value by Application (2018-2023) & (USD Million)
Table 112. Global Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value by Application (2024-2029) & (USD Million)
Table 113. Global Porcine Circovirus Type 2 (PCV2) Vaccine Average Price by Application (2018-2023) & (US$/Dose)
Table 114. Global Porcine Circovirus Type 2 (PCV2) Vaccine Average Price by Application (2024-2029) & (US$/Dose)
Table 115. North America Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Type (2018-2023) & (K Doses)
Table 116. North America Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Type (2024-2029) & (K Doses)
Table 117. North America Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Application (2018-2023) & (K Doses)
Table 118. North America Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Application (2024-2029) & (K Doses)
Table 119. North America Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Country (2018-2023) & (K Doses)
Table 120. North America Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Country (2024-2029) & (K Doses)
Table 121. North America Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 122. North America Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 123. Europe Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Type (2018-2023) & (K Doses)
Table 124. Europe Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Type (2024-2029) & (K Doses)
Table 125. Europe Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Application (2018-2023) & (K Doses)
Table 126. Europe Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Application (2024-2029) & (K Doses)
Table 127. Europe Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Country (2018-2023) & (K Doses)
Table 128. Europe Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Country (2024-2029) & (K Doses)
Table 129. Europe Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 130. Europe Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 131. Asia-Pacific Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Type (2018-2023) & (K Doses)
Table 132. Asia-Pacific Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Type (2024-2029) & (K Doses)
Table 133. Asia-Pacific Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Application (2018-2023) & (K Doses)
Table 134. Asia-Pacific Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Application (2024-2029) & (K Doses)
Table 135. Asia-Pacific Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Region (2018-2023) & (K Doses)
Table 136. Asia-Pacific Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Region (2024-2029) & (K Doses)
Table 137. Asia-Pacific Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 138. Asia-Pacific Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 139. South America Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Type (2018-2023) & (K Doses)
Table 140. South America Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Type (2024-2029) & (K Doses)
Table 141. South America Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Application (2018-2023) & (K Doses)
Table 142. South America Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Application (2024-2029) & (K Doses)
Table 143. South America Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Country (2018-2023) & (K Doses)
Table 144. South America Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Country (2024-2029) & (K Doses)
Table 145. South America Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 146. South America Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 147. Middle East & Africa Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Type (2018-2023) & (K Doses)
Table 148. Middle East & Africa Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Type (2024-2029) & (K Doses)
Table 149. Middle East & Africa Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Application (2018-2023) & (K Doses)
Table 150. Middle East & Africa Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Application (2024-2029) & (K Doses)
Table 151. Middle East & Africa Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Region (2018-2023) & (K Doses)
Table 152. Middle East & Africa Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity by Region (2024-2029) & (K Doses)
Table 153. Middle East & Africa Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 154. Middle East & Africa Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 155. Porcine Circovirus Type 2 (PCV2) Vaccine Raw Material
Table 156. Key Manufacturers of Porcine Circovirus Type 2 (PCV2) Vaccine Raw Materials
Table 157. Porcine Circovirus Type 2 (PCV2) Vaccine Typical Distributors
Table 158. Porcine Circovirus Type 2 (PCV2) Vaccine Typical Customers
LIST OF FIGURES
Figure 1. Porcine Circovirus Type 2 (PCV2) Vaccine Picture
Figure 2. Global Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value Market Share by Type in 2022
Figure 4. WH Type Examples
Figure 5. LG Type Examples
Figure 6. SH Type Examples
Figure 7. SD Type Examples
Figure 8. ZJ C Type Examples
Figure 9. Others Examples
Figure 10. Global Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 11. Global Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value Market Share by Application in 2022
Figure 12. Piglets Examples
Figure 13. Adults Pigs Examples
Figure 14. Global Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity (2018-2029) & (K Doses)
Figure 17. Global Porcine Circovirus Type 2 (PCV2) Vaccine Average Price (2018-2029) & (US$/Dose)
Figure 18. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity Market Share by Manufacturer in 2022
Figure 19. Global Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value Market Share by Manufacturer in 2022
Figure 20. Producer Shipments of Porcine Circovirus Type 2 (PCV2) Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 21. Top 3 Porcine Circovirus Type 2 (PCV2) Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Top 6 Porcine Circovirus Type 2 (PCV2) Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 23. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 24. Global Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 25. North America Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 26. Europe Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 27. Asia-Pacific Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 28. South America Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 29. Middle East & Africa Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 30. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 31. Global Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value Market Share by Type (2018-2029)
Figure 32. Global Porcine Circovirus Type 2 (PCV2) Vaccine Average Price by Type (2018-2029) & (US$/Dose)
Figure 33. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 34. Global Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value Market Share by Application (2018-2029)
Figure 35. Global Porcine Circovirus Type 2 (PCV2) Vaccine Average Price by Application (2018-2029) & (US$/Dose)
Figure 36. North America Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 37. North America Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 38. North America Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 39. North America Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 40. United States Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Canada Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Mexico Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Europe Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 44. Europe Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 45. Europe Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 46. Europe Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 47. Germany Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. France Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. United Kingdom Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Russia Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Italy Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Asia-Pacific Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 53. Asia-Pacific Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 54. Asia-Pacific Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 55. Asia-Pacific Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 56. China Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Japan Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Korea Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. India Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Southeast Asia Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Australia Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. South America Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 63. South America Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 64. South America Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 65. South America Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 66. Brazil Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Argentina Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 68. Middle East & Africa Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 69. Middle East & Africa Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 70. Middle East & Africa Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 71. Middle East & Africa Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 72. Turkey Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Egypt Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Saudi Arabia Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. South Africa Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. Porcine Circovirus Type 2 (PCV2) Vaccine Market Drivers
Figure 77. Porcine Circovirus Type 2 (PCV2) Vaccine Market Restraints
Figure 78. Porcine Circovirus Type 2 (PCV2) Vaccine Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of Porcine Circovirus Type 2 (PCV2) Vaccine in 2022
Figure 81. Manufacturing Process Analysis of Porcine Circovirus Type 2 (PCV2) Vaccine
Figure 82. Porcine Circovirus Type 2 (PCV2) Vaccine Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source
Figure 1. Porcine Circovirus Type 2 (PCV2) Vaccine Picture
Figure 2. Global Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value Market Share by Type in 2022
Figure 4. WH Type Examples
Figure 5. LG Type Examples
Figure 6. SH Type Examples
Figure 7. SD Type Examples
Figure 8. ZJ C Type Examples
Figure 9. Others Examples
Figure 10. Global Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 11. Global Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value Market Share by Application in 2022
Figure 12. Piglets Examples
Figure 13. Adults Pigs Examples
Figure 14. Global Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity (2018-2029) & (K Doses)
Figure 17. Global Porcine Circovirus Type 2 (PCV2) Vaccine Average Price (2018-2029) & (US$/Dose)
Figure 18. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity Market Share by Manufacturer in 2022
Figure 19. Global Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value Market Share by Manufacturer in 2022
Figure 20. Producer Shipments of Porcine Circovirus Type 2 (PCV2) Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 21. Top 3 Porcine Circovirus Type 2 (PCV2) Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Top 6 Porcine Circovirus Type 2 (PCV2) Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 23. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 24. Global Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 25. North America Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 26. Europe Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 27. Asia-Pacific Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 28. South America Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 29. Middle East & Africa Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 30. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 31. Global Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value Market Share by Type (2018-2029)
Figure 32. Global Porcine Circovirus Type 2 (PCV2) Vaccine Average Price by Type (2018-2029) & (US$/Dose)
Figure 33. Global Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 34. Global Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value Market Share by Application (2018-2029)
Figure 35. Global Porcine Circovirus Type 2 (PCV2) Vaccine Average Price by Application (2018-2029) & (US$/Dose)
Figure 36. North America Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 37. North America Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 38. North America Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 39. North America Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 40. United States Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Canada Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Mexico Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Europe Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 44. Europe Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 45. Europe Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 46. Europe Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 47. Germany Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. France Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. United Kingdom Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Russia Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Italy Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Asia-Pacific Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 53. Asia-Pacific Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 54. Asia-Pacific Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 55. Asia-Pacific Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 56. China Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Japan Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Korea Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. India Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Southeast Asia Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Australia Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. South America Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 63. South America Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 64. South America Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 65. South America Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 66. Brazil Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Argentina Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 68. Middle East & Africa Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 69. Middle East & Africa Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 70. Middle East & Africa Porcine Circovirus Type 2 (PCV2) Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 71. Middle East & Africa Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 72. Turkey Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Egypt Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Saudi Arabia Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. South Africa Porcine Circovirus Type 2 (PCV2) Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. Porcine Circovirus Type 2 (PCV2) Vaccine Market Drivers
Figure 77. Porcine Circovirus Type 2 (PCV2) Vaccine Market Restraints
Figure 78. Porcine Circovirus Type 2 (PCV2) Vaccine Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of Porcine Circovirus Type 2 (PCV2) Vaccine in 2022
Figure 81. Manufacturing Process Analysis of Porcine Circovirus Type 2 (PCV2) Vaccine
Figure 82. Porcine Circovirus Type 2 (PCV2) Vaccine Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source
